Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymic peptides for hospitalized COVID-19 in Honduras
NCT04771013Phase 2Completed
- Sponsor
- Universidad Católica de Honduras
- Start
- Feb 2021
- Primary completion
- May 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymopeptide in coronavirus disease 2019 (COVID-19), sponsored by Universidad Católica de Honduras. Started Feb 2021; status: completed.
02
Drugs
thymopeptide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04771013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771013.